Researchers develop first ever guideline for cancer screening in rare muscle disease

Researchers from the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Center (BRC) and University of Manchester have been instrumental in developing the first guideline for cancer screening in an inflammatory muscle disease called “myositis,” which has an increased cancer risk.

Leave A Comment

Your email address will not be published. Required fields are marked *